PHARMA
Quarterly rpt on consolidated results for the financial period ended 30 Sep 2023
| PHARMANIAGA BERHAD |
| Financial Year End | 31 Dec 2023 |
| Quarter | 3 Qtr |
| Quarterly report for the financial period ended | 30 Sep 2023 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
30 Sep 2023
|
30 Sep 2022
|
30 Sep 2023
|
30 Sep 2022
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
885,486
|
894,939
|
2,614,674
|
2,618,215
|
| 2 | Profit/(loss) before tax |
-56,259
|
-14,153
|
-40,724
|
27,807
|
| 3 | Profit/(loss) for the period |
-49,047
|
-13,227
|
-43,957
|
16,543
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
-49,339
|
-13,987
|
-44,731
|
14,469
|
| 5 | Basic earnings/(loss) per share (Subunit) |
-3.67
|
-1.07
|
-3.33
|
1.10
|
| 6 | Proposed/Declared dividend per share (Subunit) |
0.00
|
0.60
|
0.00
|
1.90
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
-0.1830
|
-0.2820
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 29 Nov 2023 |
| Category | Financial Results |
| Reference Number | FRA-29112023-00029 |